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Abstract
The amphibian model Xenopus, has been used extensively over the past century to study multiple 
aspects of cell and developmental biology. Xenopus offers advantages of a non-mammalian 
system, including high fecundity, external development, and simple housing requirements, with 
additional advantages of large embryos, highly conserved developmental processes, and close 
evolutionary relationship to higher vertebrates. There are two main species of Xenopus used in 
biomedical research, Xenopus laevis and Xenopus tropicalis; the common perception is that both 
species are excellent models for embryological and cell biological studies, but only Xenopus 
tropicalis is useful as a genetic model. The recent completion of the Xenopus laevis genome 
sequence combined with implementation of genome editing tools, such as TALENs (transcription 
activator-like effector nucleases) and CRISPR-Cas (clustered regularly interspaced short 
palindromic repeats-CRISPR associated nucleases), greatly facilitates the use of both Xenopus 
laevis and Xenopus tropicalis for understanding gene function in development and disease. In this 
paper, we review recent advances made in Xenopus laevis and Xenopus tropicalis with TALENs 
and CRISPR-Cas and discuss the various approaches that have been used to generate knockout and 
knock-in animals in both species. These advances show that both Xenopus species are useful for 
genetic approaches and in particular counters the notion that Xenopus laevis is not amenable to 
genetic manipulations.
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Introduction
With the advent of customizable genome editing technologies, such as TALENs 
(transcription activator-like effector nucleases) and CRISPR-Cas (clustered regularly 
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interspaced short palindromic repeats-CRISPR associated), it is now possible to model 
human genetic disorders in any animal or cellular system, including previously non-genetic 
models such as Xenopus laevis (Harrison et al., 2014; Peng et al., 2014). These advances 
provide researchers with a broader range of animal models, allowing them to choose the 
most experimentally tractable and biologically relevant system in which to test the function 
of specific disease-associated genes. In this review, we discuss the application of new 
genome editing technologies in both Xenopus laevis and Xenopus tropicalis, and how these 
advances will enhance our understanding of the molecular mechanisms underlying human 
disease.
Xenopus has many experimental advantages that make it a well-suited model for the study 
and functional characterization of candidate genes involved in human disease. The Xenopus 
tropicalis genome contains orthologues of 79% of the identified human disease genes 
(Hellsten et al., 2010; Khokha, 2012). Both Xenopus species have been used to study all 
aspects of vertebrate embryology, such as gastrulation, axis development and organ 
formation, dating back to the nineteenth century. These studies have provided insight into 
highly conserved members of major signal transduction pathways, for instance, BMPs and 
Wnts (Bier and De Robertis, 2015; Hikasa and Sokol, 2013). Notably, Sir John Gurdon 
(2012) and Professor Tim Hunt (2001) were awarded Nobel prizes for their ground-breaking 
research performed in Xenopus laevis (Gurdon, 2013; Hunt, 2002). The ease with which X. 
laevis and X. tropicalis embryos can be cultured in simple buffers and raised to adulthood 
enables the use of this model in most laboratory settings. Due to the large number of 
progeny that can be obtained from a single mating, Xenopus provides ample embryonic 
tissue for a wide range of experimental assays, including phenotypic analyses, RNAseq, 
ChIPseq and proteomics (Chung et al., 2014; Onjiko et al., 2015; Peshkin et al., 2015; Wühr 
et al., 2014; Yanai et al., 2011). Because of their relatively large size and ability to develop 
in culture, Xenopus embryos are particularly amenable to studies focused on manipulating 
gene function via microinjection of morpholinos, DNA constructs, translated capped RNA, 
and protein. Overexpression or misexpression of wildtype or dominant negative proteins 
were facilitated by simple and efficient transgenesis approaches, by a variety of means, 
including restriction enzyme mediated integration (REMI), I-SceI meganuclease or 
transposon mediated insertion of constructs into the Xenopus genome, and are reviewed 
elsewhere (Buchholz, 2012; Ishibashi et al., 2012b; 2012c; Kelley et al., 2012). In addition, 
the ability to fate map cell lineages from various embryonic blastomeres and tissue regions 
in Xenopus has greatly enhanced our understanding of the developmental, genetic, and 
evolutionary origin of adult structures and organs, which is essential for determining disease 
etiology (Chalmers and Slack, 2000; M. C. Lane and Sheets, 2006). These experimental 
advantages, together with their rapid external development, detailed temporal staging atlas, 
and relative transparency facilitate gene function assessment, making both Xenopus species 
versatile model systems for disease research and phenotypic drug screening (Harland and 
Grainger, 2011; Schmitt et al., 2014).
Among aquatic vertebrate model animals, Xenopus excels by having comparable organ 
development and morphology to mammalian systems, but with the added benefit of being 
able to regenerate adult tissues, such as optic nerve, lens, spinal cord and limb tissue (Blitz 
et al., 2006; Muñoz et al., 2015; Slack et al., 2008). Xenopus animals and oocytes are used 
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extensively to understand normal organ function and disease in humans (Labonne and Zorn, 
2015), including cardiac congenital heart disorders and heterotaxy (Boskovski et al., 2013; 
Duncan and Khokha, 2016; Fakhro et al., 2011; Kaltenbrun et al., 2011; Langdon et al., 
2012; 2007), gastrointestinal and pancreatic diseases (Kofent and Spagnoli, 2016; Pearl et 
al., 2009; 2011; Salanga and Horb, 2015; Womble et al., 2016), endocrine functions and 
disorders (Buchholz, 2015), kidney disease (Lienkamp, 2016), lung development (Rankin et 
al., 2011; 2015; Wallmeier et al., 2014), cancer (Chernet and Levin, 2013; Cross and 
Powers, 2009; Hardwick and Philpott, 2015; Haynes-Gilmore et al., 2014; Van 
Nieuwenhuysen et al., 2015; Wylie et al., 2015), ciliopathies (Kim et al., 2010; Klos Dehring 
et al., 2013; Ma et al., 2014), orofacial defects (Dickinson, 2016), and neurodevelopmental 
disorders (Erdogan et al., 2016; Pratt and Khakhalin, 2013). Looking forward, Xenopus is 
poised to take advantage of the new developments in genomics and genome engineering to 
better understand the molecular mechanisms underlying human disease (Harland and 
Grainger, 2011; Labonne and Zorn, 2015).
While genetics is available in fish and mice as surrogate systems for understanding human 
biology and disease, the development of Xenopus genetics offers a number of advantages 
not found in other organisms. Unlike the mouse, Xenopus embryos can be produced in large 
numbers and are accessible throughout their development, simplifying phenotypic screening 
at embryonic stages. Xenopus shares surprising similarities with humans both at the level of 
its genome and its anatomy. The frog genome has long regions in which genes exhibit 
remarkably similar syntenic relationships to those found in the human genome (Amodeo et 
al., 2015; Blitz, 2012; Blitz et al., 2013; Bodart and Duesbery, 2006; Davidson, 1973; Grant 
et al., 2015; Hellsten et al., 2010; Paranjpe et al., 2013; Roe et al., 1985; Showell et al., 
2011; Uno et al., 2013). In many cases, orthologous genes are found in equivalent regions of 
the human and frog genomes, in which the order of genes along the chromosomes is largely 
conserved. In fact, the vast majority of the breaks in synteny are from single exon genes 
identified by automated ORF prediction algorithms but not supported by EST evidence 
(Blitz, 2012; Geach et al., 2012; Krylov and Tlapakova, 2015; Macha et al., 2012; Pollet and 
Mazabraud, 2006; Showell and Conlon, 2007). Therefore, shared synteny may be even more 
prevalent than is currently thought. Moreover, while it is well established that mice are 
genetically tractable, mice are difficult for live imaging or biochemistry. Thus by combining 
genome editing with the advantages of both Xenopus species, researchers have the unique 
opportunity to integrate systems level genomic and proteomic analyses with quantitative live 
imaging of cell behaviors in genetically approachable vertebrate model systems.
Xenopus laevis versus Xenopus tropicalis
Currently, there are two main Xenopus species used in biomedical research, Xenopus laevis 
and Xenopus tropicalis. Historically, X. laevis has been the predominant Xenopus species 
studied since the 1950s due to its large size, ability to ovulate year round, and experimental 
robustness. These animals can be grown between 18–23°C in basic salt solutions, in 
relatively simple aquatic housing. They are the animal of choice for many biomedical 
researchers, including those using the Xenopus oocyte model to study ion channel 
electrophysiology, cell protein biochemistry, cell cycle biology, and cytoskeletal dynamics, 
as well as those employing the Xenopus embryo model to study development (Dubaissi and 
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Papalopulu, 2011; Kay and Peng, 1991; Maksaev and Haswell, 2015; Mitchison et al., 
2015). One of the drawbacks often cited with X. laevis is its poor genetic tractability, which 
was thought due to its allotetraploid genome and relatively long generation time of 10–12 
months; thus, most researchers have had little interest in the genetic background of X. laevis 
and have purchased outbred genetically heterogeneous frogs from commercial vendors. 
However, in the past 5 years, an inbred strain of X. laevis, known as the J strain, has become 
available through the National Xenopus Resource and the European Xenopus Resource 
Centre (Gantress et al., 2003; Pearl et al., 2012; Tochinai and Katagiri, 1975), and the J 
strain draft genome sequence is now available on Xenbase (http://www.xenbase.org; X. 
laevis Genome Project Consortium). This newly sequenced strain will allow for more 
genetic analyses in X. laevis and when combined with recent advances in genome editing 
technologies, has made it possible for essentially any lab to make mutants through targeted 
reverse genetics. In more recent years, X. tropicalis has become increasingly used as a 
genetic model because it offers the same embryological benefits as X. laevis, but has a 
shorter generation time of 5–7 months, a smaller size, and a diploid genome. However, water 
conditions are slightly different for X. laevis and X. tropicalis, and hence they require 
separate housing systems, making it more expensive for individual labs to maintain colonies 
of both species. In light of these considerations, most researchers focus on one model 
species, but both species offer unique advantages that are being exploited by the wider 
Xenopus community.
Inbred J strain X. laevis and Nigerian X. tropicalis frogs can be purchased from the National 
Xenopus Resource (NXR) in the US or the European Xenopus Resource Center (EXRC) in 
the UK. These resource centers were established in the past 10 years to serve as the main 
stock centers for the Xenopus community for inbred, transgenic and mutant lines (Pearl et 
al., 2012). Their recent advances in husbandry have optimized X. laevis maintenance, and it 
is now possible to perform in vitro fertilization from males as young as 4 months old, which 
has decreased the time required to raise lines of X. laevis (Horb, M.E. unpublished). In 
addition, these stock centers have worked to improve the cryopreservation of X. laevis and 
X. tropicalis sperm, allowing subsequent matings and the sharing of colony lines among the 
community. These improvements bring Xenopus more in line with other model systems and 
enable the proper maintenance and distribution of different strains and lines from both 
species.
Complete sequencing of both X. laevis and X. tropicalis genomes has revealed larger regions 
of synteny, and presumably the sharing of a longer common evolutionary history, with 
humans than those of other popular model systems (Hellsten et al., 2010). X. tropicalis is the 
only diploid species in the Xenopus genus, and its genome is comprised of twenty 
chromosomes, whereas X. laevis is an allotetraploid species that arose from the interspecific 
hybridization of two diploid species, and its genome consists of 36 chromosomes (Matsuda 
et al., 2015; Uno et al., 2013). There are nine pairs of homeologous chromosomes in X. 
laevis, which are named Long (L) and Short (S) that functionally segregate as two separate 
diploid genomes (Matsuda et al., 2015; Tymowska, 1991). A new nomenclature for the X. 
laevis chromosomes was recently established based on their phylogenetic relationship and 
length, such that the homeologous chromosomes are named Xla1L and Xla1S through 
Xla9L and Xla9S (Matsuda et al., 2015). The first eight pairs of X. laevis chromosomes 
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correspond to those of X. tropicalis, whereas the ninth chromosome pair contains fusions of 
chromosomes 9 and 10 from X. tropicalis and thus, they are also named Xla9_10L and 
Xla9_10S to emphasize their phylogenetic relationship. As the name implies, S 
chromosomes are shorter than L chromosomes, and this is due to loss of genes on the S 
chromosomes; it has been postulated that at least 17%, but perhaps as much as 50%, of the 
genes in X. laevis remain in a diploid/singleton state due to loss of genes on the S 
chromosomes (Hellsten et al., 2007; Uno et al., 2013), making the generation of mutants 
relatively simple for such target genes. These genome annotation advances, together with the 
recently completed Xenopus ORFeome project (Grant et al., 2015) that identified 
orthologues of 2,724 human genes associated with an Online Mendelian Inheritance in Man 
(OMIM)-recognized disease, makes X. laevis an ideal model to study vertebrate 
development and human disorders.
All of the benefits discussed above demonstrate that both Xenopus species are excellent 
model systems that will be greatly enhanced with emerging genome-editing methodology. 
These revolutionizing technologies will allow for the rapid creation of mutant frogs to model 
human diseases, providing an abundant source of material for functional studies. Utilizing 
genome editing methods in Xenopus laevis and Xenopus tropicalis will provide a cost 
effective platform to rapidly identify, validate, and characterize genes involved in human 
diseases, which will ultimately provide more detailed mechanistic insight to guide new 
therapeutic strategies. Below, we describe the use of TALENs and CRISPR-Cas based 
methods in Xenopus, and highlight some of the emerging applications of these methods to 
understand human diseases.
Genome Editing Tools in Xenopus
In the past few years numerous methods have been generated to efficiently edit the genomes 
of almost any cell type or organism, including the amphibian models Xenopus laevis and 
tropicalis, through the use of Zinc Finger Nucleases (ZFNs), Transcription Activator-Like 
Effector Nucleases (TALENs) and Clustered Regularly Interspaced Short Palindromic 
Repeats (CRISPR-Cas) nuclease systems (Harrison et al., 2014; Peng et al., 2014). The 
nucleases are targeted to a specific region of interest in the genome through the 
microinjection of sequence-specific RNA constructs, and induce double/single-stranded 
breaks in the DNA sequence. Upon recognizing this damage, the cell uses non-homologous 
end joining (NHEJ) or homology-directed repair (HDR) to repair the break. NHEJ produces 
random insertions or deletions (indels) into the target site, thereby causing potential DNA 
coding frame shifts and altered protein translation. HDR, on the other hand, uses a template 
sequence to repair the broken DNA strands; this enables the insertion of exogenous DNA 
sequences, such as fluorescent reporter transgenes to track gene expression and cell lineage, 
or point mutations mimicking known human single nucleotide polymorphisms (SNP) 
associated with a disease trait. As both TALENs and CRISPR-Cas systems have proven to 
be more versatile than ZFNs, we will focus on these more recently described gene-editing 
methods that have revolutionized basic biology as well as biomedical and other translational 
research.
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TALENs in Xenopus
Originally identified in the plant pathogen Xanthomonas, TALE proteins are transcriptional 
activators that specifically bind and regulate plant gene expression upon infection (Joung 
and Sander, 2013; Kim and Kim, 2014). The TALE structure comprises a central domain 
harboring specific repeating units of 33–35 amino acids that target individual DNA bases 
(Bogdanove and Voytas, 2011). These repeat variable di-residue (RVD) domains enable 
TALE proteins to target almost any genomic region of interest. Site-specific TALE proteins 
can be tethered to endonucleases to modify genome sequence, or to transcriptional effector 
proteins, such as VP16 and KRAB, to regulate gene activity in most eukaryotic organisms 
tested to date. To induce DNA breaks and modify genome sequences, two TALEN arms are 
required to recognize and bind the DNA sequence with a small 15–25 base spacer region in 
between. This spacer allows the dimerization of the tethered Fok1 endonuclease catalytic 
domains, thereby enabling its enzymatic function. Cloning individual TALENs is a multi-
day process that involves piecing together individual RVDs to create custom repeat arrays 
targeted to a specific DNA sequence (Cermak et al., 2011).
The first use of TALEN-induced mutations in Xenopus were performed in X. tropicalis, 
demonstrating efficient somatic and germline mutagenesis (Ishibashi et al., 2012a; Lei et al., 
2012). The initial study targeted eight Xenopus genes involved in human disease, and 
showed that TALENs induced mutations in F0 embryos with a high efficiency at all eight 
loci (Lei et al., 2012). In particular, they demonstrated that injection of TALENs targeting 
the pancreatic transcription factor ptf1a resulted in pancreatic agenesis in F0 tadpoles, 
mimicking the phenotype seen in humans and confirming previous morpholino knockdown 
phenotypes observed in Xenopus (Afelik et al., 2006; Jarikji et al., 2007; Sellick et al., 
2004), with efficient germline transmission of mutations. In addition, they showed that 
TALEN mutagenesis is more efficient and less toxic when compared directly to ZFNs, with 
no detectable off-target effects (Lei et al., 2012). Another study by the Chen lab showed that 
TALEN-mediated disruption of the n-myc downstream regulated 1 (ndgr1) gene in X. 
tropicalis displayed a similar phenotype to that observed using morpholino knockdown of 
the gene in X. laevis (Zhang et al., 2013). More recently, a comprehensive study by the 
Grainger lab demonstrated that X. tropicalis is a useful model for understanding the 
developmental basis of human eye disorders. They performed an extensive characterization 
of different TALEN-induced mutations in the pax6 gene and identified several different 
phenotypes in both F0 and F1 frogs (Nakayama et al., 2015). This group found that partial 
loss of function of pax6 in F1 animals resulted in froglets with an underdeveloped iris, a 
phenotype similar to that observed in human aniridia. Collectively, these initial studies 
demonstrated that TALEN-mediated genome editing works efficiently in F0 X. tropicalis, 
and that these mutations are transmitted through the germline.
Xenopus not only provides a platform for the study of genes involved in congenital 
malformations, but also for the study of genes involved in developmental processes and 
diseases at later stages. Recent studies by the Shi and Buchholz labs demonstrated that 
TALEN-mediated genome editing is an effective method to induce mutations in genes 
involved in hormonal control of metamorphosis in F0 X. tropicalis tadpoles, specifically in 
thyroid hormone receptor, alpha (thra) gene (Choi et al., 2015; Wen et al., 2015; Wen and 
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Shi, 2015). Choi et al. showed that F0 phenotype analysis and germline transmission of the 
TALEN-induced mutations are facilitated by injection into one cell of two-cell embryos. The 
Vleminckx lab used TALENs to create mutations in the X. tropicalis tumor suppressor gene 
adenomatous polyposis coli (apc), which is implicated as the initiating mutation in many 
colorectal cancers, including familial adenomatous polyposis (FAP) syndrome (Van 
Nieuwenhuysen et al., 2015). These studies demonstrated F0 tadpoles derived from embryos 
injected with apc-specific TALENs develop intestinal hyperplasia and other neoplasms 
commonly observed in FAP patients within 6 weeks providing a useful model for the rapid 
testing of chemical compounds to treat FAP. These results therefore demonstrate that it is 
possible to utilize the mosaic nature of TALEN-induced mutagenesis for studying advanced 
developmental events as well as tumorigenesis in Xenopus tadpoles.
Circumventing embryonic lethality in F0 animals
One of the potential problems in generating mutant Xenopus lines using TALENs is that, in 
some instances, the mutations result in embryonic lethality, thus limiting analysis to the F0 
generation. Ideally, the best way to overcome this issue would be to induce mutations only in 
germ cells and not in somatic tissue. In Xenopus, there are two methods used to create such 
germ cell-specific mutants. The first is to limit the translation of injected mRNA to germ 
cells. Several maternal mRNAs have specific germ cell restricted translation due to the 
3’UTR region, such as the gene ddx25 (Kataoka et al., 2006). Recent work from the Yaoita 
lab showed that the ddx25 3’UTR is sufficient for largely restricting translation of TALEN-
injected mRNAs to the germ cells (Nakajima and Yaoita, 2015a). They further demonstrated 
that bi-allelic TALEN-induced mutations are present in the F0 adult germ cells and 
transmitted to the F1 generation, with limited mutations found in other organs, thus defining 
a method for creating germ cell-specific mutants using TALENs. Another method to produce 
germ cell-specific mutations is to transplant primordial germ cells from a mutant embryo 
into a wild-type host embryo. In Xenopus, this can be done by transplanting a portion of the 
vegetal hemisphere, which contains the germ plasm of the early developing embryo, at the 
blastula stage (Yang et al., 2015). Recent work from the Cho lab showed that this method 
works well in X. tropicalis to produce F0 adults that are wild-type in the soma, but contain 
bi-allelic mutations in the germ cells (Blitz and Cho personal communication); adults 
produced using this method can be mated to create F1 null progeny. These two methods will 
help speed up the process of analyzing null mutations and allow for more detailed studies of 
mutations that are embryonic lethal. In addition, because Xenopus have long life spans (over 
10 years), the mutant adults can be used for many years.
Although inducing mutations in both homeologs in the allotetraploid X. laevis is, in 
principal, more difficult to achieve, several recent studies have revealed that it is possible to 
generate highly efficient gene knockouts in both homeologs in X. laevis. The complication 
with X. laevis is that, if the alloalleles are thought to be functionally redundant, mutations 
must be induced in both homeologs on the S and L chromosomes. The first reports of the 
effectiveness of TALENs in X. laevis showed that a single TALEN pair can be designed to 
target both homeologous genes, and they revealed that mutations can be detected as early as 
the morula stage of development (Sakane et al., 2013; Suzuki et al., 2013). Because 
sequence differences do exist between the alloalleles, it is also possible to design TALENs to 
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target only one of the homeologous genes. In one study, injection of two different pairs of 
TALENs, targeting each alloallele, into X. laevis embryos was found to induce mutations in 
each homeologous gene (Nakade et al., 2015). This study also demonstrated mutation of the 
individual homeolog was not possible when the specific TALEN binding site contained three 
mismatches to the endogenous sequence, highlighting the specificity of TALENs. Although 
these results showed that it is possible to induce mutations in both alloalleles in X. laevis, 
either separately or together, they also revealed that generating mutations in all four copies is 
not efficient enough to produce null F0 frogs due to the delay in initiating NHEJ in all cells.
Using a well-established Xenopus method called the oocyte-host transfer technique, which 
was developed to knockdown maternal transcripts, it is possible to induce mutations more 
rapidly and efficiently than traditional embryo injections. Therefore, using the oocyte-host 
transfer (OHT) technique combined with genome editing will result in less mosaic F0 
animals and more efficient germ line transmission of mutations (Fig. 1). In this method, 
heterologous mRNAs are injected into Xenopus oocytes, which are then cultured in vitro for 
24–48 hours, transferred into an ovulating host female, and the laid eggs are subsequently 
fertilized in vitro (Olson et al., 2012). Using this technique, the Yaoita lab demonstrated that 
TALEN-mediated gene disruption is more efficient when injected into oocytes rather than 
embryos (Nakajima and Yaoita, 2015b). Similarly, we found that a single TALEN pair 
targeting both tyrosinase homeologs was able to generate almost complete albinism in F0 
animals when injected into X. laevis oocytes (Ratzan et al., 2016); conversely, injection of 
these same TALENs into embryos resulted in mosaic F0 frogs, with only small patches of 
albinism (Fig. 1). Furthermore, the F0 oocyte-injected adults laid albino eggs, and when 
mated with sibling males, produced 50–75% albinism in the F1 generation; in contrast, all 
offspring from sibling-mated F0 embryo-injected adults failed to produce albino offspring, 
and very few mutations were recovered in the F1 generation (Ratzan et al., 2016).
An alternative method to induce genetic mutations prior to fertilization has recently been 
published by the Gurdon lab (Miyamoto et al., 2015a; 2015b; 2013). To forego oocyte 
transfer back into a host female and therefore abolish further surgery, they used 
intracytoplasmic sperm injection (Miyamoto et al., 2015a). In this procedure, X. laevis 
oocytes are extracted, enzymatically defolliculated and subsequently injected with TALEN 
mRNA (Fig. 1); these late stage oocytes are then matured by addition of progesterone and 
subsequently injected with a sperm mixture (to negate the need of a jelly coat for normal in 
vitro fertilization methods). This method has the benefits of being less technically 
challenging by eliminating manual oocyte defolliculation and reintroduction of injected 
oocytes in the host female. In their surviving embryos Miyamoto observed a similar striking 
mutation efficiency for the tyrosinase and pax6 genes (between 80–90%) with all four 
alloalleles being targeted. Both oocyte methods are highly efficient at inducing mutations 
early in development, and thus allows researchers to study gene function in an F0 
generation. This thereby enables the rapid assessment of disease-causing gene mutations 
without the need to establish mutant lines whilst also allowing the study of those genes that 
are essential for embryo or sexual maturation. In conclusion, these results show that 
TALENs work efficiently in X. tropicalis and X. laevis, and that whilst homeologous X. 
laevis genes can be independently targeted with two different pairs of TALENs, OHT is the 
most efficient method to generate mutations in all alloalleles in F0 animals.
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CRISPR-Cas in Xenopus
Another genome editing technique that works well in Xenopus is CRISPR-Cas, and it has 
become more widely used due to its simpler design. In prokaryotes there are chromosomal 
loci that harbor repetitive DNA sequences, termed CRISPR elements, and adjacent to these 
elements there are endonuclease gene coding regions, termed CRISPR-associated genes 
(Cas) (Bolotin et al., 2005; Jansen et al., 2002; Jinek et al., 2012; Makarova et al., 2015; 
Wright et al., 2016). This combination provides the bacteria with an acquired adaptive 
immune system capable of specifically targeting nucleic acid sequences of invading viruses 
or plasmids (Bhaya et al., 2011; Horvath and Barrangou, 2010; Karginov and Hannon, 
2010). Researchers have exploited the programmable nature of this DNA targeting nuclease 
to mutate specific genetic loci of interest in many model systems including Xenopus (Blitz 
et al., 2013; Cho et al., 2013; Cong et al., 2013; Doudna and Charpentier, 2014; Guo et al., 
2014; Harrison et al., 2014; Jinek et al., 2012; Mali et al., 2013a; Nakayama et al., 2013; 
Peng et al., 2014). To induce double strand breaks in Xenopus using CRISPR-Cas, one or 
more single guide RNAs (sgRNA) targeting a gene of interest is injected into Xenopus 
embryos together with the Cas endonuclease, either as mRNA or protein. This method is 
especially time saving when targeting multiple loci in the same embryo, because the 
sgRNAs can be generated by PCR in a single day, in contrast to the multi-day process for 
cloning TALENs. However, unlike TALENs, sgRNAs can only be designed to target regions 
containing a protospacer adjacent motif (PAM) site, limiting the regions that can be targeted.
Several recent reports in the past couple of years have shown that CRISPR-Cas is highly 
efficient in producing mutations in both X. tropicalis and X. laevis (Blitz et al., 2013; Guo et 
al., 2014; Nakayama et al., 2013; Wang et al., 2015). Initial studies attempted to optimize the 
amounts of sgRNA and Cas9 mRNA required to produce efficient mutagenesis in the F0 
generation with limited developmental defects. Generally, the amount of sgRNA required to 
produce efficient indels varies with each locus. For X. tropicalis, most loci require a range of 
50–200 pg sgRNA, whereas other loci require up to 400 pg sgRNA; for X. laevis, 300–500 
pg sgRNA is optimal, but greater for some loci. Interestingly, the amount of Cas9 mRNA 
required to induce indels varied among these studies. Two of the studies revealed that a 
relatively high amount (2.2–3 ng) of Cas9 mRNA is required to induce efficient mutagenesis 
(Blitz et al., 2013; Nakayama et al., 2013), whereas the third study showed that a much 
lower amount (300–500 pg) is sufficient (Guo et al., 2014).
These reported Cas9 dosage discrepancies may be due to the different Cas9 versions used in 
each study, which are identical at the amino acid level, but are only 80% identical at the 
nucleotide level (Cong et al., 2013; Mali et al., 2013b). As Xenopus codon usage slightly 
differs from that of humans, the use of rare codons may impact the translational efficiency of 
each Cas9 transcript, especially with the large size of the Cas9 protein. In addition, the two 
versions differ at their N- and C-termini: the Cong Cas9, used by the Chen lab, contains two 
nuclear localization sequences (NLS), one at each end, and a 3× FLAG tag at the N-
terminus, whereas the Mali Cas9, used by Cho and Grainger labs, contains a single NLS at 
the C-terminus. Comparison of the codon usage showed that the Cong Cas9 used slightly 
different codons, some of which were more optimal for X. laevis. These differences may 
explain why a lower dose of the Cong Cas9 was required in Xenopus. As both versions were 
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tested in the standard Xenopus vector, pCS2, they contain identical 5’ and 3’UTRs. These 
initial reports illustrated that CRISPR-Cas works efficiently in both X. laevis and X. 
tropicalis, but that care must be taken in selecting codon-optimized transcripts when 
performing mRNA injections of Cas9. An alternative to Cas9 mRNA is to use Cas9 protein, 
which eliminates the concerns of codon differences. The Khokha laboratory recently 
compared the efficacy of protein versus mRNA in Xenopus tropicalis and found that Cas9 
protein was more effective than mRNA (Bhattacharya et al., 2015). They also reported Cas9 
protein was able to induce mutations earlier in development than Cas9 mRNA and was less 
toxic. However, in light of the discussion of Cas9 codon usage, it is relevant to point out that 
they used Cas9 protein from PNA Bio, which contains only one NLS.
In addition to the technical importance, the Khokha group’s study also clearly demonstrated 
that X. tropicalis can be used to rapidly produce F0 phenotypes for human disease genes 
using CRISPR-Cas. As we have discussed, many candidate genes for human diseases have 
been identified, but little functional analysis of them has been possible, particularly outside a 
few model organisms. In this study, they designed sgRNAs to six human disease genes and 
showed that the F0 CRISPR mutants largely reproduced the expected disease phenotypes. 
Thus, with the increased efficiency afforded by Cas9 protein injection, F0 analysis was 
sufficient for functional screening of candidate genes involved in human disease, expanding 
the utility of the X. tropicalis model for this important application.
Beyond inducing genetic mutations, CRISPR-Cas can also be used to label specific 
chromosomal regions (Chen et al., 2013) and recent work by the Heald lab demonstrated 
how this can be applied to Xenopus (Lane et al., 2015). In this study they developed a 
technique that allows for the creation of a library of sgRNAs targeting a defined genomic 
region, which they call CRISPR EATING (everything available turned into new guides). The 
library is made by PCR amplification of specific genomic region followed by restriction 
digestion with an enzyme that cuts immediately 5’ to a PAM sequence resulting in various 
sized fragments; subsequent steps of adaptor ligations and restriction digests results in a 
mixture of 136 nt sgRNA fragments that contain a T7 RNA polymerase promoter for RNA 
transcription. The authors then complexed the sgRNAs with a recombinant catalytically 
inactive Cas9 fused to mNeon-Green (dCas9-Neon) to label specific chromosomal regions 
using Xenopus sperm nuclei in vitro. One of the main benefits of this approach is the ability 
to use Xenopus egg extracts and sperm nuclei to image genomic loci throughout the cell 
cycle. In addition to being useful for visualization of genomic loci, this approach can be 
adapted to generate mutations in larger regions of DNA that will be of benefit to making 
mutants in genes with many small exons.
Knock-in strategies in Xenopus
Several different methods have been used for many years to promote integration of 
exogenous DNA into the genome of Xenopus laevis or Xenopus tropicalis for the production 
of transgenic lines. These methods rely on random integration into the genome, and as such 
will not be discussed here, but we refer the reader to several excellent reviews that cover 
these methods in detail (Allen and Weeks, 2006; Chesneau et al., 2008; Love et al., 2011; 
Ogino et al., 2006; Takagi et al., 2013; Yergeau et al., 2009). In contrast, CRISPR-Cas and 
Tandon et al. Page 10
Dev Biol. Author manuscript; available in PMC 2017 June 15.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
TALENs can be used for site-specific integration of exogenous DNA and three recent reports 
demonstrated that this can be accomplished in Xenopus. In the first study, they used 
TALENs to create F0 knock-in X. laevis tadpoles through a microhomology-mediated end 
joining (MMEJ) strategy, which they refer to as TALEN-mediated precise integration into 
target chromosome, or TAL-PITCh (Nakade et al., 2014). They used a single homology arm, 
containing the TALEN target site (with an inverted spacer sequence) to insert exogenous 
DNA into two different loci, no29 and fgk (Fig. 2A). In the first instance, they targeted the 
start codon of no29 to knock-in a no29-GFP fusion template, whereas for fgk they targeted 
the 3’ end to insert EGFP just before the stop codon to make an endogenous fusion. In both 
instances, they found integration at the 5’ junction was precise in most cases, but at the 3’ 
junction there were often deletions and insertions. In the second study, they used CRISPR-
Cas to mediate integration of exogenous DNA in X. tropicalis and showed efficient germline 
transmission (Z. Shi et al., 2015). In contrast to traditional knock-in strategies that use 
homology-dependent integration, this study showed that targeted integration could be 
achieved independent of homology arms, as long as the sgRNA target site is included in the 
donor DNA (Fig. 2B). Although both methods showed that integration is imprecise and 
results in deletions and insertions around the target site, they illustrate that it is feasible to 
use TALENs and CRISPR-Cas for insertional mutagenesis.
While knock-in of exogenous DNA in F0 embryos is mosaic, this does not preclude all F0 
studies as illustrated by a recent study by the Mitchell lab (Jaffe et al., 2016). In that study, 
they used an elegant knock-in approach to create mosaic mutant F0 X. laevis in c21orf59, a 
gene involved in cilia polarization in multi-ciliated cells (MCC) in Xenopus (Fig. 2C). As 
there are two c21orf59 alloalleles on chromosomes 2L and 2S, the Mitchell lab developed a 
strategy that allowed them to independently verify if one or both alloalleles were mutated in 
individual cells. The injection of a single sgRNA to target both gene homeologs was coupled 
with the incorporation of two different donor vectors harboring either BFP or RFP reporter 
genes. These vectors differed in their homology arm DNA sequence that would target them 
specifically to either the Xla2L or Xla2S alloallele. Using this approach, they identified 
those cells where one or both alloalleles was disrupted. Cells that expressed both BFP and 
RFP displayed a complete loss of cilia polarity, whereas cells that expressed only BFP or 
RFP displayed an intermediate phenotype. Such an approach takes good advantage of the 
different alloalleles in Xenopus laevis and illustrates a useful general method for knock-ins 
in Xenopus.
Xenopus resources for genome editing (Xenbase and NXR)
Xenbase, the Xenopus model organism bioinformatics database, is an invaluable resource 
for the design and application of reverse genetics in Xenopus (James-Zorn et al., 2015). 
Xenbase (http://www.xenbase.org) is a unique resource that serves as the central repository 
for all things related to Xenopus genomics. It provides a user-friendly interface to 
interrogate data related to a specific gene, and in particular, it provides essential genomic 
sequences and web-based tools for genome editing. Individual gene pages in Xenbase 
provide a wealth of information for a particular gene, including functional descriptions and 
expression profiles, associations with human disease, and links to other model organism 
databases. Individual gene pages also have information about the genes in both X. tropicalis 
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and X. laevis, including both L and S homeologs in X. laevis. Each gene page provides a 
direct link to GBrowse, which allows visualization of the gene structure (exons and introns) 
and comparison of synteny with human and mouse genomes to confirm that the correct gene 
is being targeted. For an unannotated gene, a BLAST search can be performed directly in 
Xenbase to interrogate the respective genome and determine if the gene sequence is present. 
As annotation of the Xenopus genomes continues to be updated, often times a gene may not 
appear as annotated on the main gene page, but when viewed within GBrowse, the exon and 
intron information is properly annotated. Thus, it is critical to use the Xenbase BLAST 
function to identify the chromosomal location of each gene. This information is extremely 
useful when searching the X. laevis genome for both homeologs, because Xenbase will 
identify both genes on the L and S chromosomes. From GBrowse, one can then download 
the exon and intron sequences for an individual gene. Xenbase also provides useful links to 
several web-based genome editing tools for the identification of sgRNA or TALEN target 
sites. Thus, all of the information on Xenbase provides an essential platform to identify 
chromosomal locations of genes, and to design sgRNA and TALEN target sites.
Due to cost and space constraints, one of the difficulties within the Xenopus community is 
the raising and breeding of specific lines. In fact, most Xenopus laboratories are not 
experienced in breeding and maintaining mutant lines, particularly with the diploid X. 
tropicalis species that is ideal for genetic studies. For those unable to generate or breed their 
own frog lines, the National Xenopus Resource (NXR) offers a custom mutant service that 
will design, inject, and breed F0 or F1 X. tropicalis or X. laevis frogs. The NXR works 
closely with individual researchers to identify the specific region of a gene that should be 
mutated, and they offer multiple choices for genome editing, including TALEN and CRISPR 
sgRNA design and injection. In addition, for those researchers unable to maintain colonies 
of both X. laevis and X. tropicalis, or for those wishing to work with multiple mutant lines, 
the NXR provides a unique service called research facility service, which allows researchers 
to come to the NXR facility at the Marine Biological Laboratory (MBL) for short-term 
visits. Here, they can access the resources at the NXR, including the large number of 
different X. laevis and X. tropicalis strains and lines, and take advantage of the genome 
editing expertise at the NXR. The NXR also provides a service to raise and maintain animal 
lines at the MBL, thus allowing researchers to enhance the scope of their research. Lastly, a 
recent project funded by the NIH at the MBL, in collaboration with the NXR, is focused on 
creating 100–200 mutants for the Xenopus community. This new project works with 
individual researchers to generate CRISPR-Cas- and TALEN-mediated mutations in specific 
genes to create new Xenopus models of human disease.
Conclusions
There is substantial and growing evidence that TALENs and CRISPR-Cas genome editing 
tools can now be used to manipulate endogenous genes in both X. tropicalis and X. laevis, 
providing researchers with the powerful ability to model a host of human disorders. In 
Figure 3, we outline the steps required to generate mutants in Xenopus using TALENs or 
CRISPR-Cas systems; however, a more detailed discussion of CRISPR-Cas protocols in 
Xenopus can be found in a recent review (Nakayama et al., 2014). The design and 
application of genome editing tools for Xenopus has been streamlined by incorporating 
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online software to design target oligonucleotides and assess potential off-target effects in the 
Xenopus genome. These tools, combined with simple DNA extraction and PCR techniques 
that are already employed by most laboratories, will enable the generation and identification 
of mutant embryos in a fast and efficient manner, allowing the establishment of mutant lines 
(Fig. 3). TALENs and CRISPR-Cas can be used in a variety of ways in Xenopus to modify 
specific protein domains, rearrange chromosomal organization, or to introduce the 
equivalent human point mutations identified through genome-wide association studies 
(GWAS). In addition, unbiased studies of organ formation and function in Xenopus have 
been shown to reveal phenotypes similar to those observed in human diseases (Iwasaki and 
Thomsen, 2014; Pearl et al., 2011; Sojka et al., 2014); thus, the generation of new mutants 
via genome editing may lead to the identification of new disease candidates. Therefore, the 
genome-edited Xenopus model will be instrumental as an initial tool for understanding the 
components and pathways affected by genetic disorders in a highly conserved vertebrate in 
vivo environment, which is not yet achievable with primary cell cultures or mammalian 
models. Furthermore, when coupled with high-throughput assays that require tissue explants 
and/or large numbers of embryonic samples, the genome-edited Xenopus model should aid 
the discovery of chemical or gene therapeutics that may serve to treat human diseases.
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Figure 1. Genome editing using Xenopus embryos or oocytes
A comparison of the steps required to generate Xenopus mutants using either embryo 
injection or oocyte-host transfer methods. (A) For the embryo injection method, TALEN or 
CRISPR-Cas9 capped mRNA and/or protein is microinjected into fertilized embryos at the 
one-cell stage. The embryos are genotyped to confirm editing efficiency using PCR-
sequencing, T7 endonuclease assays, or high-resolution melt analysis. The F0 mosaic 
embryos are allowed to develop, and gene function is analyzed using a host of established 
assays, including in situ hybridization (ISH) and immunohistochemistry (IHC). These 
embryos, once grown to adulthood, can be tested for germline transmission to generate 
subsequent mutant lines. (B) An image of a mutant frog generated from embryos injected at 
the one-cell stage with TALEN mRNAs targeting the tyrosinase gene shows mosaic 
pigmentation throughout the skin. (C) For the oocyte-host transfer method, stage VI oocytes 
are surgically removed from an adult female frog, manually defollicated, and microinjected 
with TALENs or CRISPR-Cas9 capped mRNA and/or protein. The oocytes are then matured 
using progesterone and colored with vital dyes for visualization; the coloring of oocytes is 
not necessary if implanted into an albino female. The oocytes are then transferred into pre-
primed host females and subsequently laid to incorporate the jelly coat that is essential for in 
vitro fertilization with sperm. The resulting embryos are genotyped and phenotyped as 
previously described. (D) An image of a mutant frog generated from oocytes injected with 
the same TALENs as in panel B, targeting the tyrosinase gene, shows more dramatic levels 
of albinism than the embryo-injected frog, thereby confirming more efficient mutagenesis.
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Fig. 2. Integrating exogenous DNA into Xenopus using genetic editing tools
Outline of the various knock-in strategies that have been employed to insert DNA into a 
targeted genomic locus in Xenopus. (A) Nakade et al. described the use of TALENs and 
microhomology-mediated end joining (MMEJ, TAL-PITCh) to integrate a fluorescent 
protein (eg. GFP) at the end of the coding region 5’ to the endogenous stop codon. (B) Shi et 
al. utilized CRISPR-Cas editing to insert plasmid DNA harboring a known pancreas tissue 
enhancer element (Elastase promoter) driving GFP, into the intron of their target gene. (C) 
Jaffe et al, used targeting constructs containing allele-specific homology arms to insert 
fluorescent proteins into an sgRNA-targeted exon, thereby visualizing cells in which specific 
gene function was abrogated. TAA; stop codon, FokI; Fok1 nuclease, GFP; green 
fluorescent protein, pA; poly-A tail, sgRNA; guide RNA for CRISPR.
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Figure 3. Workflow for generating Xenopus mutants using TALENs and CRISPR-Cas9
A schematic depicts the steps required to generate the gene editing tools to target a gene of 
interest, induce mutations in Xenopus embryos, perform subsequent assays to phenotype 
mosaic F0 embryos, and generate mutant lines. For more detailed information including web 
URLs we refer the reader to Xenbase (http://www.xenbase.org/other/static/CRISPr.jsp).
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